Starboard slashes stake in Kohl's after seeking to buy it in January




  • In Business
  • 2022-08-12 22:13:41Z
  • By Reuters
 

By Svea Herbst-Bayliss

BOSTON (Reuters) - Activist hedge fund Starboard Value, which had offered to buy Kohl's Corp for roughly $9 billion early this year, slashed its stake in the department store by more than 80% in the second quarter, according to a regulatory filing on Friday evening.

Starboard sold 2.8 million shares during the quarter, leaving it with 535,029 shares on June 30.

Starboard first invested in Kohl's during the first quarter of 2022 and the firm owned 2.59% of the company's stock, making it a top 10 holder. Investment managers are beginning to release their quarterly holdings before Monday's so-called 13-F filing deadline which details what they owned in U.S.-based companies on June 30.

In early January, before takeover talk for Kohl's heated up, the stock traded around $50 a share. On Friday, Kohl's shares closed at $33.18.

On July 1, Kohl's said it had called off its sale to Franchise Group, sending the company's shares tumbling.

Starboard-backed Acacia Research Corp in January offered to buy Kohl's for $64 a share and told the company it had assurances of obtaining financing for the deal. Kohl's rejected Starboard's overtures.

Months later the company agreed to negotiate exclusively with Franchise Group Inc, which owns Vitamin Shoppe and Buddy's Home Furnishings. In late June, Franchise Group cut its offer for Kohl's to $53 and by the end of the month the company called off the planned deal, citing market volatility which had made financing conditions difficult.

Kohl's defeated hedge fund Macellum Advisors' proxy contest to win board seats in part with arguments that the current board should oversee the sales process which was ongoing.

(Reporting by Svea Herbst-Bayliss in Boston; Editing by Matthew Lewis)

COMMENTS

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

  • Bobbygef
    (2022-08-13 04:27:01Z)

    que es mejor cialis o viagra o levitra [url=https://kwxcva.estranky.cz/clanky/cialis-20-mg.html#]cialis 20mg [/url]
    cialis par internet cialis 20mg
    cialis pills without a prescription https://mewser.mystrikingly.com/

    REPLY
  • Bobbygef
    (2022-08-13 06:13:08Z)

    navarro pharmacy miami [url=https://graph.org/Pharmacies-in-canada-shipping-to-usa-08-12#]canada pharmaceuticals online [/url]
    pharmacy discount pharmacy on line
    online pharmacies legitimate https://telegra.ph/Recommended-canadian-pharmacies-08-12

    REPLY
  • Bobbygef
    (2022-08-13 08:18:40Z)

    cialis side effects eye [url=https://sbwerd.estranky.sk/clanky/cialis-generic-pharmacy-online.html#]tadalafil 20 mg [/url]
    viagra and cialis on sale cialis prices
    viagra cialis bestellen https://my.desktopnexus.com/Buycialis/journal/cialis-without-a-doctor-prescription-38780/

    REPLY
  • Bobbygef
    (2022-08-13 09:58:07Z)

    drugstore online [url=https://kwenzx.nethouse.ru/#]medicine online shopping [/url]
    canada pharmacy compound pharmacy
    canadian cialis https://graph.org/Pharmacies-in-canada-shipping-to-usa-08-12

    REPLY
  • Bobbygef
    (2022-08-13 15:24:15Z)

    canadia online pharmacy [url=https://dwerks.nethouse.ru/#]canadian pharcharmy [/url]
    canada drugs pharmacy online medicine online shopping
    canadian pharmaceuticals online safe https://kwenzx.nethouse.ru/

    REPLY
  • Bobbygef
    (2022-08-13 17:28:53Z)

    buy followup post cialis soft [url=https://sbwerd.estranky.sk/clanky/cialis-generic-pharmacy-online.html#]cialis online [/url]
    50mg viagra vs 20mg cialis online cialis
    buy online prescription vaniqa cialis soft https://kwxcva.estranky.cz/clanky/cialis-20-mg.html

    REPLY
  • Bobbygef
    (2022-08-13 19:08:42Z)

    canadian drugs pharmacies online [url=https://linktr.ee/canadianpharmacies#]online pharmacies in usa [/url]
    canada drugs pharmacy pharmacy uk
    walgreens pharmacy online https://graph.org/Pharmacies-in-canada-shipping-to-usa-08-12

    REPLY

Top News: Business